Emmessar Biotech & Nutrition informs about outcome of board meeting

24 Apr 2025 Evaluate

Emmessar Biotech & Nutrition has informed that the Board of Directors at their meeting held today April 24, 2025 has transacted the following items of business: Financial Results: The Board of Directors approved the Audited Standalone Financial Results for the year ended 31.03.2025 along with the Statement of Assets and Liabilities for the year ended 31.03.2025 in the specified format along with the Auditors Report thereon. The above results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their meeting(s) held on April 24, 2025. The company has enclosed are the Audited statements and declaration on Audit report with unmodified opinion. The Meeting commenced at 12:10 pm and concluded at 14.25 pm.

The above information is a part of company’s filings submitted to BSE.

Emmessar Biotech&Nut Share Price

29.20 0.15 (0.52%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×